Search Results for "Ixora Coccinea For Treatment Of Cancer"
Original Source: Ixorapeptide I and ixorapeptide II, bioactive peptides isolated from Ixora coccinea.
Two novel derivatized peptides, designated as ixorapeptide I (1) and ixorapeptide II (2), in addition to 28 other known compounds, were isolated from the MeOH extract of Ixora coccinea using bioassay-guided fractionation. The structures of metabolites 1 and 2 were determined by interpretation of the spectroscopic data and Marfey's method. Compound 1 exhibited selective potency against Hep3B liver cancer cell line with an IC(50) value of 3.36 μg/mL, and compound 2 did not show notable cytotoxicity toward ca...
Matching Channels
Breast cancer in the UK is diagnosed in nearly 46,000 people each year, with just over 12,000 dying from breast cancer each year in he UK. There are several risk factors for developing b...
Colon or Colorectal cancer is the growth of malignant polyps on the colon, bowel, anus and rectum. Growths in these locations can be benign, and removed by colonoscopy, but they have a risk of becom...
Tumor markers are substances produced by tumor cells or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. These substances can be found in the blood, in t...
Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or...
On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...
Matching News
A Look At The Prostate Cancer Treatment Market
ByEmerging Equities:According to research firm RNCOS, the number of newly diagnosed global cancer cases is expected to reach over 17 million by 2020. The U.S. is the largest market for cancer drugs....
A Look At The Prostrate Cancer Treatment Market
ByEmerging Equities:According to research firm RNCOS, the number of newly diagnosed global cancer cases is expected to reach over 17 million by 2020. The U.S. is the largest market for cancer drugs....
Bespoke (i.e, Customized) Cancer Treatment; Cancer "Cures" and the Media
Patients with cancer need to seek the most sophisticated care that they can obtain these days, which is usually found in cancer centers and academic hospitals (see: Patients with a Cancer Should Seek...
Fatigue Experienced By Cancer Patients Reduced By Aerobic Exercise
Aerobic exercise can help relieve the fatigue often associated with cancer and cancer treatment, according to Cochrane researchers. Their updated systematic review strengthens findings from an earlier...
Neighboring non-cancer cells may contribute to drug resistance
One of cancer's most frightening characteristics is its ability to return after treatment. In the case of many forms of cancer, including the skin cancer known as melanoma, tailored drugs can eradicat...
After Cancer: Debate About Terminology Beyond Treatment
At present, patients who recover from cancer treatment are generally referred to as cancer survivors, but does this adequately capture life beyond cancer? Medscape Medical News
Tumor microenvironment helps skin cancer cells resist drug treatment
One of cancer's most frightening characteristics is its ability to return after treatment. In the case of many forms of cancer, including the skin cancer known as melanoma, tailored drugs can eradicat...
A new route for tackling treatment-resistant prostate cancer
(University of Rochester Medical Center) Scientists have identified a new treatment target for men with advanced prostate cancer that no longer responds to hormone therapy - a stage of the disease whi...
Matching PubMed Articles
Ixorapeptide I and ixorapeptide II, bioactive peptides isolated from Ixora coccinea.
Two novel derivatized peptides, designated as ixorapeptide I (1) and ixorapeptide II (2), in addition to 28 other known compounds, were isolated from the MeOH extract of Ixora coccinea using bioassay-...
Antioxidant activity and total phenolic content of methanol extracts of Ixora coccinea.
Objective: To investigate the in vitro antioxidant activity of methanol extracts of Ixora coccinea L. (Rubiaceae) flower, leaf and stem. Materials and methods: The 2,2-diphenyl-1-picrylhydrazyl (DPPH)...
Ixora coccinea Linn.: Traditional uses, phytochemistry and pharmacology.
Ixora coccinea Linn., (Rubiaceae) commonly known as jungle of geranium and red ixora, is an evergreen shrub found throughout India. Depending on the medical condition, the flowers, leaves, roots, and...
Phytochemical investigation of the ethyl acetate fraction of the methanol extract of the leaves of Ixora coccinea led to the isolation and identification of an A-type trimeric proanthocyanidin epicate...
Two new triterpenoid acids from Kadsura coccinea.
An investigation of EtOAc extracts of Kadsura coccinea (Lem.) A. C. Smith, has led to the isolation of two new compounds characterized as 3-hydroxy-12-hydroxyl coccinic acid (1) and 3-hydroxy-neokadsu...
